GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials
NEW ORLEANS — A fixed-dose combination of novel amylin analog cagrilintide and semaglutide, given once weekly, lowered blood glucose and weight in various populations with type 2 diabetes. The combination…
